Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug467 | BI 730357 Wiki | 1.00 |
| drug795 | CRESTOR® Wiki | 1.00 |
| drug3130 | Proxalutamide Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D011470 | Prostatic Hyperplasia NIH | 1.00 |
| D006965 | Hyperplasia NIH | 1.00 |
| D000505 | Alopecia NIH | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0008711 | Benign prostatic hyperplasia HPO | 1.00 |
| HP:0002293 | Alopecia of scalp HPO | 0.71 |
Navigate: Correlations HPO
There is one clinical trial.
The main objective of this trial is to investigate the effect of BI 730357 under steady state conditions on the pharmacokinetics of digoxin, furosemide, metformin and rosuvastatin given as a cocktail (Reference, R: cocktail alone; Test T: cocktail given under steady state conditions of BI 730357).
Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports